
Monoacylglycerol lipase - Wikipedia
Monoacylglycerol lipase (EC 3.1.1.23; systematic name glycerol-ester acylhydrolase, also known as MAG lipase, acylglycerol lipase, MAGL, MGL or MGLL) is an enzyme that, in humans, is encoded by the MGLL gene.
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Monoacylglycerol lipase (MAGL) has been characterized as the main enzyme responsible for the inactivation of the most abundant brain endocannabinoid, 2-arachidonoylglycerol (2-AG).
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in ...
Dec 5, 2023 · Monoacylglycerol lipase (MAGL) regulates endocannabinoid 2-arachidonoylglycerol (2-AG) and eicosanoid signalling. MAGL inhibition provides therapeutic opportunities but clinical potential is...
MAGL (Monoacylglycerol Lipase): An Endocannabinoid …
Dec 4, 2019 · Monoacylglycerol Lipase (MAGL) is the specialized enzyme that breaks down the endocannabinoid 2-AG, and it represents the point at which the endocannabinoid system dovetails with a system of signaling agents called eicosanoids.
Monoacylglycerol lipase inhibitors: modulators for lipid …
Monoacylglycerol lipase (MAGL) plays a crucial role catalysing the hydrolysis of monoglycerides. MAGL inhibitors have been considered as important agents in many therapeutic fields, including anti-nociceptive, anti-inflammatory and anti-cancer.
MAGL: Insights Into Lipid Metabolism and Therapy
Mar 17, 2025 · MAGL is the primary enzyme responsible for hydrolyzing monoacylglycerols (MAGs) into free fatty acids and glycerol, playing a crucial role in lipid metabolism. This process regulates intracellular lipid pools, balancing storage and mobilization.
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for ...
Monoacylglycerol lipase (MAGL) is a key enzyme involved in the metabolism of 2-AG (2-arachidonoylglycerol), a neuroprotective endocannabinoid intimately linked to the generation of pro- and anti-inflammatory molecules. Consequently, synthesizing selective MAGL inhibitors has become a focus point in drug design and development.
Monoacylglycerol Lipase: A Novel Potential Therapeutic Target …
Oct 21, 2016 · Monoacylglycerol lipase (MAGL) is a key enzyme in lipid metabolism that is demonstrated to be involved in tumor progression through both energy supply of fatty acid (FA) oxidation and enhancing...
Inhibition of monoacylglycerol lipase, an anti-inflammatory and ...
Monoacylglycerol lipase (MAGL) is the rate-limiting enzyme in the degradation of monoacylglycerols. It is a proinflammatory enzyme that metabolises 2-arachidonoylglycerol, an endocannabinoid receptor ligand, into arachidonic acid. Here, we investigated the impact of MAGL on inflammation and fibrosis during chronic liver injury.
Monoacylglycerol Lipase | Hydrolases | Tocris Bioscience
Monoacylglycerol lipase (MAGL, MGL) is a hydrolase that is involved in endocannabinoid and triglyceride hydrolysis. It is the primary enzyme responsible for the metabolism of 2-arachidonylglycerol (2-AG) in the brain, and is also involved in lipid signaling.